Bhattacharjee Rahul, Dubey Ankit Kumar, Ganguly Archisha, Bhattacharya Basudha, Mishra Yogendra Kumar, Mostafavi Ebrahim, Kaushik Ajeet
KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.
Institute of Scholars, Chikmagalur, Karnataka 577102, India.
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
The emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants made emerging novel coronavirus diseases (COVID-19) pandemic/endemic/or both more severe and difficult to manage due to increased worry about the efficacy and efficiency of present preventative, therapeutic, and sensing measures. To deal with these unexpected circumstances, the development of novel nano-systems with tuneable optical, electrical, magnetic, and morphological properties can lead to novel research needed for (1) COVID-19 infection (anti-microbial systems against SARS-CoV-2), (2) early detection of mutated SARS-CoV-2, and (3) targeted delivery of therapeutics using nano-systems, i.e., nanomedicine. However, there is a knowledge gap in understanding all these nano-biotechnology potentials for managing mutated SARS-CoV-2 on a single platform. To bring up the aspects of nanotechnology to tackle SARS-CoV-2 variants related COVID-19 pandemic, this article emphasizes improvements in the high-performance of nano-systems to combat SARS-CoV-2 strains/variants with a goal of managing COVID-19 infection via trapping, eradication, detection/sensing, and treatment of virus. The potential of state-of-the-art nano-assisted approaches has been demonstrated as an efficient drug delivery systems, viral disinfectants, vaccine productive cargos, anti-viral activity, and biosensors suitable for point-of-care (POC) diagnostics. Furthermore, the process linked with the efficacy of nanosystems to neutralize and eliminate SARS-CoV-2 is extensively highligthed in this report. The challenges and opportunities associated with managing COVID-19 using nanotechnology as part of regulations are also well-covered. The outcomes of this review will help researchers to design, investigate, and develop an appropriate nano system to manage COVID-19 infection, with a focus on the detection and eradication of SARS-CoV-2 and its variants. This article is unique in that it discusses every aspect of high-performance nanotechnology for ideal COVID pandemic management.
新出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种,由于人们对现有预防、治疗和检测措施的有效性和效率越来越担心,使得新出现的新型冠状病毒疾病(COVID-19)大流行/地方性流行/或两者兼而有之的情况变得更加严重且难以控制。为应对这些意外情况,开发具有可调节光学、电学、磁学和形态学特性的新型纳米系统,可带来以下方面所需的新研究:(1)COVID-19感染(针对SARS-CoV-2的抗菌系统),(2)变异SARS-CoV-2的早期检测,以及(3)使用纳米系统进行治疗药物的靶向递送,即纳米医学。然而,在理解所有这些纳米生物技术在单个平台上管理变异SARS-CoV-2的潜力方面,存在知识空白。为了提出纳米技术在应对与SARS-CoV-2变种相关的COVID-19大流行方面的应用,本文强调提高纳米系统的高性能,以对抗SARS-CoV-2毒株/变种,目标是通过捕获、根除、检测/传感和治疗病毒来控制COVID-19感染。先进的纳米辅助方法已被证明具有作为高效药物递送系统、病毒消毒剂、疫苗生产载体、抗病毒活性以及适用于即时检测(POC)诊断的生物传感器的潜力。此外,本报告广泛强调了与纳米系统中和及消除SARS-CoV-2功效相关的过程。作为法规一部分,使用纳米技术管理COVID-19相关的挑战和机遇也得到了充分涵盖。本综述的结果将有助于研究人员设计、研究和开发合适的纳米系统来控制COVID-19感染,重点是检测和根除SARS-CoV-2及其变种。本文的独特之处在于,它讨论了用于理想的COVID大流行管理的高性能纳米技术的各个方面。